These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18777458)

  • 1. Association of impaired glucose metabolism in morbid obesity with hypoadiponectinaemia.
    Schinner S; Kempf K; Overmann H; Willenberg HS; Schott M; Rose B; Scherbaum WA; Herder C
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S64-9. PubMed ID: 18777458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus.
    Catalán V; Gómez-Ambrosi J; Rotellar F; Silva C; Gil MJ; Rodríguez A; Cienfuegos JA; Salvador J; Frühbeck G
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):598-601. PubMed ID: 17371481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
    Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-based population data indicates the significant alterations of insulin resistance, chronic inflammation and urine ACR in IFG combined IGT group among prediabetic population.
    Lü Q; Tong N; Liu Y; Li N; Tang X; Zhao J; Cao H; Li D; Gou L; Zhang Y; Wan J; Jiang L
    Diabetes Res Clin Pract; 2009 Jun; 84(3):319-24. PubMed ID: 19442860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients.
    Alberti L; Gilardini L; Girola A; Moro M; Cavagnini F; Invitti C
    Diabetes Obes Metab; 2007 May; 9(3):344-9. PubMed ID: 17391161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects.
    Bruun JM; Helge JW; Richelsen B; Stallknecht B
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E961-7. PubMed ID: 16352667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.
    Dogru T; Sonmez A; Tasci I; Bozoglu E; Yilmaz MI; Genc H; Erdem G; Gok M; Bingol N; Kilic S; Ozgurtas T; Bingol S
    Diabetes Res Clin Pract; 2007 Apr; 76(1):24-9. PubMed ID: 16956691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.
    Snijder MB; Heine RJ; Seidell JC; Bouter LM; Stehouwer CD; Nijpels G; Funahashi T; Matsuzawa Y; Shimomura I; Dekker JM
    Diabetes Care; 2006 Nov; 29(11):2498-503. PubMed ID: 17065691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes.
    Wallander M; Söderberg S; Norhammar A
    Diabet Med; 2008 Aug; 25(8):949-55. PubMed ID: 18959608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction.
    Nyström T; Nygren A; Sjöholm A
    Clin Sci (Lond); 2006 Jun; 110(6):673-81. PubMed ID: 16466346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
    Chacón MR; Fernández-Real JM; Richart C; Megía A; Gómez JM; Miranda M; Caubet E; Pastor R; Masdevall C; Vilarrasa N; Ricard W; Vendrell J
    Obesity (Silver Spring); 2007 Mar; 15(3):664-72. PubMed ID: 17372317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
    Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
    Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors.
    Müller S; Martin S; Koenig W; Hanifi-Moghaddam P; Rathmann W; Haastert B; Giani G; Illig T; Thorand B; Kolb H
    Diabetologia; 2002 Jun; 45(6):805-12. PubMed ID: 12107724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoadiponectinemia and proinflammatory state: two sides of the same coin?: results from the Cooperative Health Research in the Region of Augsburg Survey 4 (KORA S4).
    Herder C; Hauner H; Haastert B; Röhrig K; Koenig W; Kolb H; Müller-Scholze S; Thorand B; Holle R; Rathmann W
    Diabetes Care; 2006 Jul; 29(7):1626-31. PubMed ID: 16801589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease.
    Roubicek T; Bartlova M; Krajickova J; Haluzikova D; Mraz M; Lacinova Z; Kudla M; Teplan V; Haluzik M
    Nutrition; 2009; 25(7-8):762-8. PubMed ID: 19539174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
    Mraz M; Bartlova M; Lacinova Z; Michalsky D; Kasalicky M; Haluzikova D; Matoulek M; Dostalova I; Humenanska V; Haluzik M
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism.
    Blüher M; Fasshauer M; Tönjes A; Kratzsch J; Schön MR; Paschke R
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):534-7. PubMed ID: 16235156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.